Sort by:

select Language:



WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update

Dennis Falzon, Elizabeth Harausz, Ernesto Jaramillo et al., Eds.: World Health Organization (WHO), (2016)



https://www.ncbi.nlm.nih.gov/books/n/who250125/pdf...


mhGAP Intervention Guide app

World Health Organization WHO, (2017)


WHO’s mhGAP Intervention Guide 2.0 app, launched in October, is now available in both iOS and Android. The app provides non-specialized health-care providers with access to comprehensive information to help them diagnose and treat a range of mental, neurological and substance use (MNS) disorders including depression, epilepsy and dementia from their tablets or mobile phones. Each module includes a description and guidance on assessment and management of priority MNS conditions. The tool can be downloaded free of charge. It is currently available in English. Other languages are expected to be available soon Download the iOS Version under: https://itunes.apple.com/gb/app/mhgap-ig-2-0-app-e-mhgap/id1291414206?mt=8 The Android Version under: https://play.google.com/store/apps/details?id=com.universaltools.mhgap
http://www.who.int/mental_health/mhgap/e_mhgap/en/


Diphtheria vaccine: WHO position paper – August 2017. Vaccin antidiphtérique: Note de synthèse de l’OMS – août 2017

World Health Organization WHO, (2017)


Weekly epidemiological record/ Relevé épidémiologique hebdomadaire 4 AUGUST 2017, 92th YEAR / 4 AOÛT 2017, 417-436
http://www.who.int/entity/immunization/policy/pos...


Landscape for HIV rapid diagnostic tests for HIV self-testing

World Health Organization WHO; UNITAID, (2017)


This third edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United Nation’s 90-90-90 targets. In particular, the report synthesises the existing and emerging market demand and supply of kits. The information in this report is intended for manufacturers, donors, national programmes, researchers and other global health stakeholders who are exploring the potential role of HIVST.
http://www.who.int/entity/hiv/pub/vct/unitaid-land...


Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection

World Health Organization WHO, (2016)


2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and care
http://apps.who.int/iris/bitstream/10665/208825/1/...


Vacina da dengue: qual é a recomendação?

ANVISA Agência Nacional de Vigilância Sanitária , (2017)


Bula da vacina foi atualizada com nova recomendação para vacina da dengue da Sanofi Aventis para pessoas nunca infectadas pela dengue.
https://tinyurl.com/y9cqm5tw


Consolidated guidelines on person-centred HIV patient monitoring and case surveillance

World Health Organization WHO, (2017)


This guideline recommend the use of unique identifiers to link patients across health services, allowing the sustainable measurement of the cascade of services. The guidelines promote the use of routine data for patient care and enable reporting on most programme, national and global indicators, including key global targets for HIV.
http://apps.who.int/iris/bitstream/10665/255702/1/...


Policy brief: Consolidated guideline on HIV prevention, diagnosis, treatment and care for key populations. Update 2016

World Health Organization WHO, (2017)


This is the 2016 update of the policy brief on the consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations.
http://apps.who.int/iris/bitstream/10665/258967/1/...


752 hits